Hot List BioTech; IMMU, TLIF, IBB
Immunomedics, Inc. (NASDAQ:IMMU)
Immunomedics, Inc. is a clinical-stage biopharmaceutical company developing monoclonal antibody-based products for the targeted treatment of cancer, autoimmune disorders and other serious diseases. The Company’s technologies allow it to create humanized antibodies in unlabeled or naked form, or conjugated with radioactive isotopes, chemotherapeutics, cytokines or toxins. Its product candidates include 90Y-clivatuzumab tetraxetan. Its radiolabeled antibody is in a Phase III registration trial in patients with advanced pancreatic cancer. Its portfolio of investigational products also includes antibody-drug conjugates (ADCs). Its ADCs consist of sacituzumab govitecan (IMMU-132) and labetuzumab govitecan (IMMU-130), which are in Phase II trials for a number of solid tumors and metastatic colorectal cancer (mCRC), respectively. It has other product candidates that target solid tumors and hematologic malignancies, as well as other diseases, in clinical and pre-clinical development-stages.
IMMUNOMEDICS closed down -0.037 at 3.813. Volume was 96% below average (consolidating) and Bollinger Bands were 58% wider than normal.
Open High Low Close Volume___
3.860 3.870 3.810 3.813 40,708
Technical Outlook
Short Term: Overbought
Intermediate Term: Bullish
Long Term: Bullish
Moving Averages: 10-period 50-period 200-period
Close: 3.71 2.91 2.50
Volatility: 83 68 102
Volume: 1,659,662 1,001,470 1,113,286
Short-term traders should pay closer attention to buy/sell arrows while intermediate/long-term traders should place greater emphasis on the Bullish or Bearish trend reflected in the lower ribbon.
Summary
IMMUNOMEDICS is currently 52.6% above its 200-period moving average and is in an upward trend. Volatility is extremely high when compared to the average volatility over the last 10 periods. There is a good possibility that volatility will decrease and prices will stabilize in the near term. Our volume indicators reflect very strong flows of volume into IMMU.O (bullish). Our trend forecasting oscillators are currently bullish on IMMU.O and have had this outlook for the last 25 periods.
iShares NASDAQ Biotechnology Index (ETF) (NASDAQ:IBB)
iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.
ISH NASDAQ BIOTC closed down -1.350 at 262.700. Volume was 96% below average (consolidating) and Bollinger Bands were 2% narrower than normal.
Open High Low Close Volume___
264.770 264.800 262.070 262.700 87,775
Technical Outlook
Short Term: Neutral
Intermediate Term: Bearish
Long Term: Bearish
Moving Averages: 10-period 50-period 200-period
Close: 264.11 267.30 306.56
Volatility: 32 37 42
Volume: 1,785,595 2,228,588 2,480,336
Short-term traders should pay closer attention to buy/sell arrows while intermediate/long-term traders should place greater emphasis on the Bullish or Bearish trend reflected in the lower ribbon.
Summary
ISH NASDAQ BIOTC is currently 14.3% below its 200-period moving average and is in an downward trend. Volatility is low as compared to the average volatility over the last 10 periods. Our volume indicators reflect moderate flows of volume out of IBB.O (mildly bearish). Our trend forecasting oscillators are currently bearish on IBB.O and have had this outlook for the last 5 periods.
Tocca Life Holdings Inc (OTCMKTS:TLIF)
TOCCA Life Holdings, Inc. (OTC PINK: TLIF): Located in Lake Worth, and Boynton Beach, Florida, the first publicly traded sober living company focused on biotech industry solutions to create accountability through technology and early detection, TOCCA Life offers clients more than the typical halfway house, recovery residence, sober or transitional living experience by opening up doors of interest that may spark a client’s new passion for life while practicing the 12 Step Program in its safe, structured sober living environment. Extra precautions are being taken for the clients and the community with clinical toxicology testing, to monitor prescription drug use and make clients accountable for illicit drug use, as clients transform themselves back into productive members of society.
TOCCA LIFE HLDG closed up 0.009 at 0.045. Volume was 82% below average (consolidating) and Bollinger Bands were 98% narrower than normal.
Open High Low Close Volume___
0.045 0.045 0.045 0.045 10,000
Technical Outlook
Short Term: Neutral
Intermediate Term: Neutral
Long Term: Bullish
Moving Averages: 10-period 50-period 200-period
Close: 0.04 0.06 847.34
Volatility: 179 496 1,070
Volume: 28,432 48,496 25,585
Short-term traders should pay closer attention to buy/sell arrows while intermediate/long-term traders should place greater emphasis on the Bullish or Bearish trend reflected in the lower ribbon.
Summary
TOCCA LIFE HLDG gapped up (bullish) on light volume. Possibility of a Common Gap which usually coincides with a lack of interest in the security. Common Gaps are fairly irrelevent for forecasting purposes. Four types of price gaps exist – Common, Breakaway, Runaway, and Exhaustion. Gaps acts as support/resistance.
TOCCA LIFE HLDG is currently 100.0% below its 200-period moving average and is in an downward trend. Volatility is extremely low when compared to the average volatility over the last 10 periods. There is a good possibility that there will be an increase in volatility along with sharp price fluctuations in the near future. Our volume indicators reflect volume flowing into and out of TLIF.PK at a relatively equal pace (neutral). Our trend forecasting oscillators are currently turning bullish on TLIF.PK and have had this outlook for the last 7 periods.
The post Hot List BioTech; IMMU, TLIF, IBB appeared first on Live Trading News.